SCHEMBL5754973

SCHEMBL5754973

CCCCOC(=O)NC(CO)Cc1ccc(N)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.49
LMNA P02545 2/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2C9 P11712 1/20 0.49
TSHR P16473 1/20 0.49
CYP2C19 P33261 1/20 0.49
PDE4D Q08499 1/20 0.49
NPC1 O15118 5/20 0.44
RAB9A P51151 5/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
HPGD P15428 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAPT P10636 2/20 0.44
ALDH1A1 P00352 2/20 0.44
CNR1 P21554 1/20 0.42
MAPK1 P28482 3/20 0.40
CTSK P43235 2/20 0.40
CHRM2 P08172 1/20 0.40
HTR1A P08908 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5752656 1.00 CYP3A4 (0.49) CYP3A4LMNACYP1A2CYP2C9TSHR
Butyl Alcohol SCHEMBL5756750 0.96 CYP3A4 (0.46) CYP3A4LMNACYP1A2CYP2C9TSHR
Butyl Alcohol SCHEMBL5756752 0.96 CYP3A4 (0.46) CYP3A4LMNACYP1A2CYP2C9TSHR
SCHEMBL31008760 0.88 SMN1; SMN2 (0.57) CYP3A4LMNACYP1A2CYP2C9TSHR
SCHEMBL8749524 0.87 CYP3A4 (0.55) CYP3A4LMNACYP1A2CYP2C9TSHR
SCHEMBL29603779 0.87 CYP3A4 (0.55) CYP3A4LMNACYP1A2CYP2C9TSHR
SCHEMBL27732754 0.85 MMEL1 (0.50) CYP3A4MAPK1CTSKCTRB1
SCHEMBL909961 0.82 ITGB3 (0.52) CYP3A4LMNACYP1A2CYP2C9TSHR
SCHEMBL5752780 0.82 ITGB3 (0.52) CYP3A4LMNACYP1A2CYP2C9TSHR
SCHEMBL7495527 0.82 TSHR (0.49) CYP3A4LMNACYP1A2CYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0843673-B1 ONE POT SYNTHESIS OF 2-OXAZOLIDINONE DERIVATIVES ASTRAZENECA AB (SE) 2001-11-07 EP claimed
EP-1227095-B1 A process for the purification of (S)-4-((3-(dimethylamino)ethyl)-1H-indol-5yl)-methyl)-2-oxazolidinone ASTRAZENECA AB (SE) 2006-05-03 EP disclosed
US-6909005-B1 One post synthesis of 2-oxazolidinone derivatives ASTRAZENECA UK LIMITED (GB) 2005-06-21 US disclosed
EP-0843672-B1 ONE POT SYNTHESIS OF 2-OXAZOLIDINONE DERIVATIVES ASTRAZENECA AB (SE) 2002-11-13 EP disclosed
EP-1227095-A2 A process for the purification of (S)-4-((3-(dimethylamino)ethyl)-1H-indol-5yl)-methyl)-2-oxazolidinone AstraZeneca AB (SE) 2002-07-31 EP disclosed
EP-0843673-B1 ONE POT SYNTHESIS OF 2-OXAZOLIDINONE DERIVATIVES ASTRAZENECA AB (SE) 2001-11-07 EP disclosed